GENOTOXICITY OF BENZO[A]PYRENE DERIVATIVES AND SULFITE
GENOTOXICITY OF BENZO[A]PYRENE DERIVATIVES AND SULFITE
批准号:
3252011
负责人:
Gregory Allen Reed
金额:
$10.12万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-05-01 至 1994-06-30
关键词:
DNA RNA Salmonella typhimurium adduct autoradiography benzopyrenes chemical binding chemical carcinogen chemical carcinogenesis cocarcinogen covalent bond fibroblasts hamsters high performance liquid chromatography hydrolysis mutagen testing organ culture phosphorus physical chemical interaction proteins radiotracer sulfites sulfonate sulfur oxides toxin metabolism transfer RNA tritium
中文摘要
二氧化硫是一种无处不在的空气污染物,也是烟草的一种成分
英文摘要
Sulfur dioxide, a ubiquitous air pollutant and a component of tobacco
smoke, is a cocarcinogen for benzo[a]pyrene (BP) in the respiratory
tract. We have investigated effects of sulfite, the physiological form
of sulfur dioxide, on the metabolism and the genotoxicity of BP
metabolites. This proposal focuses on interactions of sulfite with
7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene (BP-7,8-diol) and
7r,8t-dihydroxy-9t,10t-epoxy7,8,9,10-tetrahydrobenzo[a]pyrene (anti-BPDE)
to form isomeric bay-region BPT sulfonates. These derivatives, formed in
high yield in incubations with either S. typhimurium tester strains or
with hamster trachea in organ culture, represent a novel class of
reactive intermediates. Although far more stable to hydrolysis than are
bay-region diolepoxides, these sulfonates nevertheless bind covalently to
DNA at levels comparable to those seen with the diolepoxides. Based on
our findings, we have developed and will test the hypothesis that
formation of genotoxic BPT sulfonates represents a mechanism by which
sulfur dioxide enhances BP carcinogenicity. The overall goal of this
application is to characterize the biochemical and biological factors
affecting both the formation of BPT sulfonates and their biological
activities. Chemical characterization will examine the reactivity of BPT
sulfonates with DNA, RNA, and protein. Due to the importance of DNA
modification in mutagenesis and carcinogenesis, the interactions of the
sulfonates with DNA will be studied by both 32p-postlabeling and
structural characterization of deoxynucleoside adducts. In all cases,
behavior of the sulfonates will be compared with that of anti-BPDE. The
ability of these BPT sulfonates to form in biological systems, and their
effects on these systems will be examined using the V79 hamster lung cell
line. V79 cells will be treated with anti-BPDE with and without sulfite,
or with BPT sulfonates, and the resultant BP product profile and the
induction of covalent binding to cellular macromolecules will be
determined. Finally, the genotoxic activity of BPT sulfonates will be
determined in the V79 system using selection for the hgprt phenotype.
The primary aim of this project is to characterize the chemical and
biological properties of BPT sulfonates, which represent a novel class of
reactive intermediates. If these products are formed readily in intact
mammalian cells, if they readily modify cellular nucleic acids, and if
they exert genotoxic effects in this system, then a process consistent
with the observed enhancing effect of sulfur dioxide on BP carcinogenesis
will be established.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Pharmacology Shared Resource
-
批准号:9975735
-
项目类别:
-
资助金额:$12.09万
-
财政年份:2012
-
负责人:Gregory Allen Reed
-
依托单位:
COBRE: U OF KANSAS MEDICAL CTR: ANALYTICAL CORE
-
批准号:8360783
-
项目类别:
-
资助金额:$11.29万
-
财政年份:2011
-
负责人:Gregory Allen Reed
-
依托单位:
COBRE: U OF KANSAS MEDICAL CTR: ANALYTICAL CORE
-
批准号:8167662
-
项目类别:
-
资助金额:$10.58万
-
财政年份:2010
-
负责人:Gregory Allen Reed
-
依托单位:
COBRE: U OF KANSAS MEDICAL CTR: CORE E: ANALYTICAL CORE
-
批准号:7959506
-
项目类别:
-
资助金额:$14.2万
-
财政年份:2009
-
负责人:Gregory Allen Reed
-
依托单位:
COBRE: U OF KANSAS MEDICAL CTR: CORE E: ANALYTICAL CORE
-
批准号:7720183
-
项目类别:
-
资助金额:$13.98万
-
财政年份:2008
-
负责人:Gregory Allen Reed
-
依托单位:
COBRE: U OF KANSAS MEDICAL CTR: CORE E: ANALYTICAL CORE
-
批准号:7610771
-
项目类别:
-
资助金额:$20.27万
-
财政年份:2007
-
负责人:Gregory Allen Reed
-
依托单位:
COBRE: U OF KANSAS MEDICAL CTR: CORE E: ANALYTICAL CORE
-
批准号:7382250
-
项目类别:
-
资助金额:$9.51万
-
财政年份:2006
-
负责人:Gregory Allen Reed
-
依托单位:
Probe Drugs for Botanical-Drug Interactions
-
批准号:7296133
-
项目类别:
-
资助金额:$17.84万
-
财政年份:2006
-
负责人:Gregory Allen Reed
-
依托单位:
Probe Drugs for Botanical-Drug Interactions
-
批准号:7101307
-
项目类别:
-
资助金额:$18.98万
-
财政年份:2006
-
负责人:Gregory Allen Reed
-
依托单位:
Probe Drugs for Botanical-Drug Interactions
-
批准号:7488440
-
项目类别:
-
资助金额:$17.49万
-
财政年份:2006
-
负责人:Gregory Allen Reed
-
依托单位:
PULMONARY TOXICITY OF SULFUR DIOXIDE AND SULFITE
-
批准号:3252012
-
项目类别:
-
资助金额:$6.65万
-
财政年份:1987
-
负责人:Gregory Allen Reed
-
依托单位:
GENOTOXICITY OF BENZO[A]PYRENE DERIVATIVES AND SULFITE
-
批准号:2153561
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1987
-
负责人:Gregory Allen Reed
-
依托单位:
PULMONARY TOXICITY OF SULFUR DIOXIDE AND SULFITE
-
批准号:3252013
-
项目类别:
-
资助金额:$6.89万
-
财政年份:1987
-
负责人:Gregory Allen Reed
-
依托单位:
GENOTOXICITY OF BENZO[A]PYRENE DERIVATIVES AND SULFITE
-
批准号:3252014
-
项目类别:
-
资助金额:$9.62万
-
财政年份:1987
-
负责人:Gregory Allen Reed
-
依托单位:
PULMONARY TOXICITY OF SULFUR DIOXIDE AND SULFITE
-
批准号:3252009
-
项目类别:
-
资助金额:$11.97万
-
财政年份:1987
-
负责人:Gregory Allen Reed
-
依托单位:
Clinical Pharmacology Shared Resource
-
批准号:9750032
-
项目类别:
-
资助金额:$11.86万
-
财政年份:--
-
负责人:Gregory Allen Reed
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程子译
-
依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
-
批准号:2026JJ81091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘亮
-
依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
RACK1乳酸化调控RNA损伤—核糖体应激通路介导卵巢癌铂耐药的分子机制和干预研究
-
批准号:82673836
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨毕康
-
依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
-
批准号:JCZRLH202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
24-脱氢胆固醇还原酶DHCR24作为RNA结合蛋白调控PIM1翻译促进肾透明细胞癌进展的功能机制研究
-
批准号:82606550
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2026
-
负责人:宁昊
-
依托单位:
RNA结合蛋白SORBS2调控AIM2通路介导内皮焦亡促肺动脉高压血管重构的作用与机制研究
-
批准号:2026JJ50099
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘斌
-
依托单位:
X连锁RNA结合基序蛋白通过上调CXCL8分泌诱导巨噬细胞M2型极化促进结直肠癌奥沙利铂耐药
-
批准号:2026JJ80231
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曹婷
-
依托单位: